Delaet Ingrid's Form 4 filing
Neurocrine Biosciences Inc (NBIX) · filed Jul 11, 2025
- Accession no.
- 0000914475-25-000153
- Filed
- Jul 11, 2025
- Trade date
- Jul 10, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $61.7K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Delaet IngridCIK 0001965808 | Officer (Chief Regulatory Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 10, 2025 | Common Stock | MOption exerciseAcquired | +457 | $79.02 | +$36,112.14 | 5,187 | Direct | |
| Jul 10, 2025 | Common Stock | SSaleDisposed | −457 | $135.00 | −$61,695 | 4,730 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 10, 2025 | Common Stock | MOption exerciseDisposed | −457 | $0.00 | $0 | 2,261 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.